Cargando…

FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway

OBJECTIVE: The aim of the study is to investigate the role and possible mechanism of fascin-1 (FSCN1) in the invasion, migration, glycolysis, and epithelial-mesenchymal transition (EMT) of prostate cancer. METHODS: Real-time quantitative polymerase chain reaction (qRT-PCR) was utilized to determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Minghui, Gao, Zhiming, Ding, Honglin, Wang, Zhanhua, Mu, Hada, Zhang, Lei, Wei, Jiufu, Ma, Zhanshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259215/ https://www.ncbi.nlm.nih.gov/pubmed/35815268 http://dx.doi.org/10.1155/2022/6245647

Ejemplares similares

Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Glucose promotes epithelial‐mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ
por: Li, Shi, et al.
Publicado: (2020)

FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition
por: Zhang, Yuanbiao, et al.
Publicado: (2018)

The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGFβ Signaling
por: Pseftogas, Athanasios, et al.
Publicado: (2020)

AR activates YAP/TAZ differentially in prostate cancer
por: Salem, Omar, et al.
Publicado: (2023)

Yap and Taz regulate retinal pigment epithelial cell fate
por: Miesfeld, Joel B., et al.
Publicado: (2015)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

Yap/Taz inhibit goblet cell fate to maintain lung epithelial homeostasis
por: Hicks-Berthet, Julia, et al.
Publicado: (2021)

TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma
por: Xiao, Heng, et al.
Publicado: (2015)

TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex
por: Merritt, Nicole, et al.
Publicado: (2021)

TAZ and YAP are frequently activated oncoproteins in sarcomas
por: Fullenkamp, Colleen A., et al.
Publicado: (2016)

Multifaceted regulation and functions of YAP/TAZ in tumors
por: Liu, Huirong, et al.
Publicado: (2018)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019)

YAP and TAZ in Lung Development: The Timing Is Important
por: Warburton, David
Publicado: (2020)

Emerging Principles in the Transcriptional Control by YAP and TAZ
por: Lopez-Hernandez, Alejandro, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

YAP/TAZ: Molecular pathway and disease therapy
por: Wei, Yuzi, et al.
Publicado: (2023)

Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer
por: Ou, Chunlin, et al.
Publicado: (2019)

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury
por: DiGiovanni, Gianluca T., et al.
Publicado: (2023)

Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression
por: Xie, Dacheng, et al.
Publicado: (2015)

Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer
por: Chen, Guangyuan, et al.
Publicado: (2016)

20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer
por: Li, Jie, et al.
Publicado: (2017)

Tumor Cell Glycolysis—At the Crossroad of Epithelial–Mesenchymal Transition and Autophagy
por: Marcucci, Fabrizio, et al.
Publicado: (2022)

Silibinin inhibits the migration, invasion and epithelial-mesenchymal transition of prostate cancer by activating the autophagic degradation of YAP
por: Dan, Weichao, et al.
Publicado: (2022)

Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ
por: Guo, Ling, et al.
Publicado: (2018)

Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
por: Chan, Siew Wee, et al.
Publicado: (2011)

YAP/TAZ initiate and maintain Schwann cell myelination
por: Grove, Matthew, et al.
Publicado: (2017)

The role of YAP/TAZ activity in cancer metabolic reprogramming
por: Zhang, Xiaodong, et al.
Publicado: (2018)

Relationship between Keloid Formation and YAP/TAZ Signaling
por: Aramaki-Hattori, Noriko, et al.
Publicado: (2017)

Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
por: Boopathy, Gandhi T. K., et al.
Publicado: (2019)

Effect of YAP/TAZ on megakaryocyte differentiation and platelet production
por: Lorthongpanich, Chanchao, et al.
Publicado: (2020)

The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis
por: Kovar, Heinrich, et al.
Publicado: (2020)

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway
por: Vanyai, Hannah K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0r33epinslg7hed5ue0vn4gi2p